Matches in Nanopublications for { ?s ?p ?o <http://bio2rdf.org/drugbank_resource:DB00315_DB01171_nanopub.RAYuRH_KRp3ld43dttq-E72fLJWuFxPbm2ru7RGuM71gQ#assertion>. }
Showing items 1 to 6 of
6
with 100 items per page.
- drugbank_resource:DB00315_DB01171 type drugbank_vocabulary:Drug-Drug-Interaction assertion.
- drugbank_resource:DB00315_DB01171 label "DDI between Zolmitriptan and Moclobemide - The MAO inhibitor, moclobemide, may increase the serum concentration of zolmitriptan by decreasing its metabolism. Concomitant therapy and use of zolmitriptan within two weeks of discontinuing moclobemide are contraindicated. [drugbank_resource:DB00315_DB01171]" assertion.
- drugbank_resource:DB00315_DB01171 identifier "drugbank_resource:DB00315_DB01171" assertion.
- drugbank_resource:DB00315_DB01171 title "DDI between Zolmitriptan and Moclobemide - The MAO inhibitor, moclobemide, may increase the serum concentration of zolmitriptan by decreasing its metabolism. Concomitant therapy and use of zolmitriptan within two weeks of discontinuing moclobemide are contraindicated." assertion.
- drugbank:DB01171 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00315_DB01171 assertion.
- drugbank:DB00315 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00315_DB01171 assertion.